Litigation Details for BAUSCH HEALTH IRELAND LIMITED v. MYLAN LABORATORIES LTD. (N.D.W. Va. 2022)
✉ Email this page to a colleague
BAUSCH HEALTH IRELAND LIMITED v. MYLAN LABORATORIES LTD. (N.D.W. Va. 2022)
| Docket | ⤷ Sign Up | Date Filed | 2022-03-08 |
| Court | District Court, N.D. West Virginia | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Thomas Shawn Kleeh |
| Jury Demand | None | Referred To | |
| Patents | 9,919,024; 9,925,231 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in BAUSCH HEALTH IRELAND LIMITED v. MYLAN LABORATORIES LTD.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for BAUSCH HEALTH IRELAND LIMITED v. MYLAN LABORATORIES LTD. (N.D.W. Va. 2022)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2023-03-30 | 199 | Order on Motion to Strike AND Memorandum & Opinion AND Order on Motion to Dismiss for Failure AND Order on Motion for Judgment on the Pleadings | (“the ’321 patent”), 9,616,097 (“the ’097 patent”), 9,919,024 (“the ’024 patent”), 9,925,231 (“the ’231…2 includes the ’321 patent, the ’097 patent, the ’024 patent, and the ’231 patent, which disclose and…Mylan 1 The patents-in-suit are United States Patent Nos. 7,041,786 (“the ’786 patent”), 9,610,321 (…’231 patent”), 10,011,637 (“the ’637 patent”), 11,142,549 (“the ’549 patent”), and 11,319,346 (“the ’346…Id. These patents fall into three patent families. Family 1 includes the ’786 patent, which discloses | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
